Steven Yeh, MD
Ophthalmology · Atlanta, GANPI 1689851958
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $230,107 of the $288,785 with a category attached, or 79.7%. 23 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 40.9% of the total. Among ophthalmology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 323 payments — averaging $894.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$118K
- Alcon$59K
- Apellis Pharmaceuticals, Inc.$46K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$24K
- Genentech USA, Inc.$22K
- Eyepoint US, Inc.$5K
- plus $15K from 17 others
What the payments were for
- Consulting fees$230,10780%
- Speaking & faculty fees$22,2198%
- Travel & lodging$20,9097%
- Food & beverage$15,5515%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 137 | $118,215 |
| Alcon | 79 | $59,196 |
| Apellis Pharmaceuticals, Inc. | 14 | $45,645 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 18 | $23,806 |
| Genentech USA, Inc. | 28 | $22,435 |
| Eyepoint US, Inc. | 5 | $4,528 |
| AbbVie(2 entities) | 9 | $4,406 |
| Sanofi US Services Inc. | 1 | $3,969 |
| Lupin Inc. | 3 | $2,241 |
| ANI Pharmaceuticals, Inc. | 2 | $2,146 |
| Genentech, Inc. | 5 | $349 |
| Carl Zeiss Meditec USA, Inc. | 4 | $314 |
| Alimera Sciences, Inc. | 3 | $285 |
| Novartis | 3 | $249 |
| Astellas Pharma US Inc | 2 | $206 |
| Biogen | 3 | $177 |
| Johnson & Johnson | 1 | $135 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Sun Pharmaceutical Industries Inc. | 1 | $107 |
| Dompe US, Inc. | 1 | $84 |
| Coherus Oncology, Inc. | 1 | $78 |
| Regeneron | 1 | $67 |
| Amgen | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIPERE$94,912
- Constellation$37,855
- Syfovre$20,812
- STELLARIS$20,761
- STELLARIS ELITE$18,674
- NGENUITY$11,894
- SURGICAL MISC$10,989
- Luxor$9,800
- Alcon Greishaber Finesse$9,800
- OPHTHALMIC INSTRUMENTS$9,290
- YUTIQ$5,624
- SUSVIMO$4,691
- Unity$2,000
- OZURDEX$1,492
- PROLENSA$1,000
- LOTEMAX$1,000
- CRYSTALENS$1,000
- ENVISTA$1,000
- VICTUS$1,000
- EYP-1901$925
How this compares
$288,785 in reported general payments places this provider in the 95th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 58 | $2,894 |
| Brimonidine Tartrate | 14 | $597 |
| Dexamethasone Sodium Phosphate | 12 | $581 |
| ValacyclovirValacyclovir Hcl | 13 | $472 |
| Latanoprost | 48 | $368 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 18 | $212 |
| Prednisone | 25 | $163 |
| Timolol Maleate | 18 | $149 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Atlanta
- Gagan SawhneyAtlanta$582K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Evan SchoenbergAtlanta$130K
- Robert StultingAtlanta$85K
- David SackelAtlanta$82K
- Atul SharmaAtlanta$77K
- Daniel MartinAtlanta$55K
- Douglas DayAtlanta$52K
- Jay StallmanAtlanta$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.